Cargando…

Molecular determinants of outcomes in meningiomas

Meningiomas are the most common intracranial primary tumor in adults. Surgery is the predominant therapeutic modality for symptomatic meningiomas. Although the majority of meningiomas are benign, there exists a subset of meningiomas that are clinically aggressive. Recent advances in genetics and epi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lynes, John, Flores-Milan, Gabriel, Rubino, Sebastian, Arrington, John, Macaulay, Robert, Liu, James K. C., Beer-Furlan, Andre, Tran, Nam D., Vogelbaum, Michael A., Etame, Arnold B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413043/ https://www.ncbi.nlm.nih.gov/pubmed/36033542 http://dx.doi.org/10.3389/fonc.2022.962702

Ejemplares similares

Improving Brain Metastases Outcomes Through Therapeutic Synergy Between Stereotactic Radiosurgery and Targeted Cancer Therapies
por: Rubino, Sebastian, et al.
Publicado: (2022)

TIPS-04 A RANDOMIZED, MULTI-INSTITUTIONAL PILOT STUDY TO EVALUATE THE MOLECULAR AND CELLULAR RESPONSE TO TREATMENT WITH NIVOLUMAB WITH EITHER ADJUVANT IPILIMUMAB OR RELATLIMAB IN ADULT PATIENTS WITH SURGICALLY RESECTABLE MELANOMA BRAIN METASTASES: ONGOING TRIAL
por: Pina, Yolanda, et al.
Publicado: (2023)

NTRK3 gene fusion in an adult ganglioglioma: illustrative case
por: Rubino, Sebastian, et al.
Publicado: (2022)

Use of virtual magnetic resonance imaging to compensate for brain shift during image-guided surgery: illustrative case
por: Kim, John T., et al.
Publicado: (2022)

Characterization of Immune Infiltrates Associated With Radiation Necrosis in the Setting of Brain Metastases Following Stereotactic Radiosurgery and Immunotherapy: A Retrospective Cohort Analysis
por: Jiang, Shirley, et al.
Publicado: (2023)

Molecular Mechanism and Approach in Progression of Meningioma
por: Shao, Zhiwei, et al.
Publicado: (2020)

Recent advances in the molecular prognostication of meningiomas
por: Wang, Elaina J., et al.
Publicado: (2023)

Meningioma: A Review of Clinicopathological and Molecular Aspects
por: Huntoon, Kristin, et al.
Publicado: (2020)

Corrigendum: Molecular Mechanism and Approach in Progression of Meningioma
por: Shao, Zhiwei, et al.
Publicado: (2020)

Spontaneous Spinal Subdural Hematoma Secondary to Hemophilia A and Zanubrutinib
por: Lynes, John, et al.
Publicado: (2022)

Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management
por: Wilson, Taylor Anne, et al.
Publicado: (2020)

Symptom burden and surgical outcome in non-skull base meningiomas
por: Mederer, Tobias, et al.
Publicado: (2022)

An Integrative Analysis of Meningioma Tumors Reveals the Determinant Genes and Pathways of Malignant Transformation
por: Iglesias Gómez, José Carlos, et al.
Publicado: (2014)

An Overview of Managements in Meningiomas
por: Zhao, Lianhua, et al.
Publicado: (2020)

Potential Molecular Mechanisms of Recurrent and Progressive Meningiomas: A Review of the Latest Literature
por: Peng, Wenjie, et al.
Publicado: (2022)

Patient satisfaction and cost savings analysis of the telemedicine program within a neuro-oncology department
por: Liu, James K. C., et al.
Publicado: (2022)

Corrigendum: An Overview of Managements in Meningiomas
por: Zhao, Lianhua, et al.
Publicado: (2020)

Recent Advances in Meningioma Immunogenetics
por: Al-Rashed, May, et al.
Publicado: (2020)

Identification and Management of Aggressive Meningiomas
por: Patel, Bhuvic, et al.
Publicado: (2022)

Current Options and Future Directions in Immune Therapy for Glioblastoma
por: Lynes, John, et al.
Publicado: (2018)

Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review
por: Kannapadi, Nivedha V., et al.
Publicado: (2022)

Corrigendum: Identification and management of aggressive meningiomas
por: Patel, Bhuvic, et al.
Publicado: (2022)

Five Fraction Image-Guided Radiosurgery for Primary and Recurrent Meningiomas
por: Oermann, Eric Karl, et al.
Publicado: (2013)

Postoperative Long-Term Independence Among the Elderly With Meningiomas: Function Evolution, Determinant Identification, and Prediction Model Development
por: Li, Haoyi, et al.
Publicado: (2021)

The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series
por: Roehrkasse, Amanda M., et al.
Publicado: (2022)

Clinical Factors and Outcomes of Atypical Meningioma: A Population-Based Study
por: Zhang, Gui-Jun, et al.
Publicado: (2021)

Expression and clinical value of EGFR in human meningiomas
por: Arnli, Magnus B., et al.
Publicado: (2017)

The Current State of Radiomics for Meningiomas: Promises and Challenges
por: Gu, Hao, et al.
Publicado: (2020)

CDK 4/6 inhibitors for the treatment of meningioma
por: Young, Jacob S., et al.
Publicado: (2022)

Case Report: Recurrent meningioma with multiple metastases
por: Zhou, Juyue, et al.
Publicado: (2023)

A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up
por: Padevit, Luis, et al.
Publicado: (2023)

Possible Abscopal Effect Observed in Frontal Meningioma After Localized IMRT on Posterior Meningioma Resection Cavity Without Adjuvant Immunotherapy
por: Golub, Danielle, et al.
Publicado: (2019)

Progression-Free Survival, Prognostic Factors, and Surgical Outcome of Spheno-Orbital Meningiomas
por: Masalha, Waseem, et al.
Publicado: (2021)

Canine Primary Intracranial Cancer: A Clinicopathologic and Comparative Review of Glioma, Meningioma, and Choroid Plexus Tumors
por: Miller, Andrew D., et al.
Publicado: (2019)

MAC-spinal meningioma score: A proposal for a quick-to-use scoring sheet of the MIB-1 index in sporadic spinal meningiomas
por: Wach, Johannes, et al.
Publicado: (2022)

Molecular Biological Determinations of Meningioma Progression and Recurrence
por: Linsler, Stefan, et al.
Publicado: (2014)

Radiation Treatment for WHO Grade II and III Meningiomas
por: Walcott, Brian P., et al.
Publicado: (2013)

Recurrence/Regrowth in Grade I Meningioma: How to Predict?
por: de Carvalho, Gervásio Teles Cardoso, et al.
Publicado: (2020)

Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
por: Wu, Wei, et al.
Publicado: (2020)

Sylvian Fissure Meningiomas: Case Report and Literature Review
por: Cai, Chengwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lav9s150pickt57pu1b618tk4j